Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca2+ release by Huang, Wei et al.
ORIGINAL ARTICLE
Caffeine protects against experimental acute
pancreatitis by inhibition of inositol
1,4,5-trisphosphate receptor-mediated Ca2+ release
Wei Huang,1,2,3 Matthew C Cane,2 Rajarshi Mukherjee,1,2 Peter Szatmary,1,2
Xiaoying Zhang,1,3 Victoria Elliott,1 Yulin Ouyang,1,2 Michael Chvanov,1,2
Diane Latawiec,1 Li Wen,1,3 David M Booth,2 Andrea C Haynes,4 Ole H Petersen,5
Alexei V Tepikin,2 David N Criddle,1,2 Robert Sutton1
▸ Additional material is
published online only. To view
please visit the journal online
(http://dx.doi.org/10.1136/
gutjnl-2015-309363).
1NIHR Liverpool Pancreas
Biomedical Research Unit,
Royal Liverpool University
Hospital, University of
Liverpool, Liverpool, UK
2Department of Cellular and
Molecular Physiology, Institute
of Translational Medicine,
University of Liverpool,
Liverpool, UK
3Department of Integrated
Traditional Chinese and
Western Medicine, Sichuan
Provincial Pancreatitis Centre,
West China Hospital, Sichuan
University, Chengdu, China
4Immuno-Inﬂammation
Therapeutic Area Unit,
GlaxoSmithKline, Stevenage,
UK
5Cardiff School of Biosciences,
Cardiff University, Cardiff, UK
Correspondence to
Professor Robert Sutton, NIHR
Liverpool Pancreas Biomedical
Research Unit, 5th Floor UCD,
Royal Liverpool University
Hospital, Daulby Street,
Liverpool L69 3GA, UK;
r.sutton@liverpool.ac.uk
Received 10 February 2015
Revised 31 August 2015
Accepted 22 September 2015
Published Online First
7 December 2015
To cite: Huang W,
Cane MC, Mukherjee R,
et al. Gut 2017;66:301–
313.
ABSTRACT
Objective Caffeine reduces toxic Ca2+ signals in
pancreatic acinar cells via inhibition of inositol 1,4,5-
trisphosphate receptor (IP3R)-mediated signalling, but
effects of other xanthines have not been evaluated, nor
effects of xanthines on experimental acute pancreatitis
(AP). We have determined effects of caffeine and its
xanthine metabolites on pancreatic acinar IP3R-mediated
Ca2+ signalling and experimental AP.
Design Isolated pancreatic acinar cells were exposed to
secretagogues, uncaged IP3 or toxins that induce AP and
effects of xanthines, non-xanthine phosphodiesterase
(PDE) inhibitors and cyclic adenosine monophosphate
and cyclic guanosine monophosphate (cAMP/cGMP)
determined. The intracellular cytosolic calcium
concentration ([Ca2+]C), mitochondrial depolarisation and
necrosis were assessed by confocal microscopy. Effects of
xanthines were evaluated in caerulein-induced AP (CER-
AP), taurolithocholic acid 3-sulfate-induced AP (TLCS-AP)
or palmitoleic acid plus ethanol-induced AP (fatty acid
ethyl ester AP (FAEE-AP)). Serum xanthines were
measured by liquid chromatography-mass spectrometry.
Results Caffeine, dimethylxanthines and non-xanthine
PDE inhibitors blocked IP3-mediated Ca
2+ oscillations,
while monomethylxanthines had little effect. Caffeine and
dimethylxanthines inhibited uncaged IP3-induced Ca
2+
rises, toxin-induced Ca2+ release, mitochondrial
depolarisation and necrotic cell death pathway activation;
cAMP/cGMP did not inhibit toxin-induced Ca2+ rises.
Caffeine signiﬁcantly ameliorated CER-AP with most
effect at 25 mg/kg (seven injections hourly); paraxanthine
or theophylline did not. Caffeine at 25 mg/kg signiﬁcantly
ameliorated TLCS-AP and FAEE-AP. Mean total serum
levels of dimethylxanthines and trimethylxanthines
peaked at >2 mM with 25 mg/kg caffeine but at
<100 mM with 25 mg/kg paraxanthine or theophylline.
Conclusions Caffeine and its dimethylxanthine
metabolites reduced pathological IP3R-mediated
pancreatic acinar Ca2+ signals but only caffeine
ameliorated experimental AP. Caffeine is a suitable
starting point for medicinal chemistry.
INTRODUCTION
Acute pancreatitis (AP) has an incidence of 30 per
100 000 per annum in the UK, commonly caused
by gallstones or alcohol excess.1 Most cases are
Signiﬁcance of this study
What is already known on this subject?
▸ Acute pancreatitis is a major health problem
without speciﬁc drug therapy.
▸ Coffee consumption reduces the incidence of
acute alcoholic pancreatitis.
▸ Caffeine blocks physiological intracellular Ca2+
oscillations by inhibition of inositol
1,4,5-trisphosphate receptor-(IP3R)-mediated
signalling.
▸ Sustained cytosolic Ca2+ overload from
abnormal Ca2+ signalling is implicated as a
critical trigger in the pathogenesis of acute
pancreatitis.
What are the new ﬁndings?
▸ Caffeine and its dimethylxanthine
metabolites inhibit IP3R-mediated, sustained
cytosolic Ca2+ elevations, loss of
mitochondrial membrane potential and
necrotic cell death pathway activation in
pancreatic acinar cells.
▸ Neither speciﬁc phosphodiesterase inhibitors
nor cyclic adenosine monophosphate and cyclic
guanosine monophosphate inhibit sustained
Ca2+ elevations in pancreatic acinar cells.
▸ Serum levels of xanthines after 25 mg/kg
caffeine administration are sufﬁcient to inhibit
IP3R-mediated Ca
2+ overload in experimental
acute pancreatitis.
▸ Caffeine but not theophylline or paraxanthine
administered at 25 mg/kg signiﬁcantly
ameliorated pancreatic injury in experimental
acute pancreatitis through IP3R-mediated
signalling inhibition.
How might it impact on clinical practice in
the foreseeable future?
▸ These ﬁndings support an approach of
inhibition of Ca2+ overload and of its
consequences as novel potential therapy for
acute pancreatitis.
▸ Methylxanthine-based structures are suitable
starting points for drug discovery and
development to treat acute pancreatitis.
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mild, whereas a complicated clinical course occurs in one out of
every ﬁve patients, resulting in signiﬁcant morbidity, mortality
and ﬁnancial burden.2 Over the last two decades, our under-
standing of pathogenesis has advanced, but there is still no spe-
ciﬁc therapy despite many randomised trials.2 The development
of treatments for AP is, therefore, a priority, one strategy for
which is to follow leads from complementary laboratory and
clinical studies, as here.
Intracellular Ca2+ signals control normal secretion from pan-
creatic acinar cells but can become a critical trigger in pathogen-
esis. Physiological concentrations of acetylcholine (ACh) and
cholecystokinin (CCK) generate repetitive elevations in the cyto-
solic Ca2+ concentration ([Ca2+]C) within the cellular apical
pole that elicit stimulus metabolism coupling to generate ATP
from mitochondria and stimulus-secretion coupling to initiate
exocytosis.3 Intermittently, global extension of short-lived
signals throughout the cell is necessary for nuclear signalling
contributing to transcription and translation.3 In contrast, toxins
such as bile acids,4 oxidative5 and non-oxidative metabolites6 7
of ethanol and CCK hyperstimulation8 9 each elicit abnormal
elevations of [Ca2+]C that are global and sustained. These
abnormal elevations induce premature activation of intracellular
enzymes, mitochondrial dysfunction, impaired autophagy,
vacuolisation and necrosis, all of which contribute to the patho-
genesis of AP.10 Ca2+ chelation prevents zymogen activation and
vacuolisation through attenuation of Ca2+ overload in acinar
cells in vitro11 12 and ameliorates the severity of AP in vivo.13
Blockage of the Ca2+ release-activated Ca2+ channel, also
known as the store-operated Ca2+ entry (SOCE) channel, by
Orai1 inhibitor GSK-7975A, reduces Ca2+ overload and necro-
sis in both mouse14 15 and human15 pancreatic acinar cells and
prevents AP in three different mouse models. Genetic deletion
or pharmacological inhibition of another SOCE channel, transi-
ent receptor potential cation channel 3 (TRPC3), also reduces
caerulein-induced SOCE and AP.16 17
Excessive Ca2+ release from intracellular stores occurs pre-
dominantly via inositol 1,4,5-trisphosphate receptor (IP3R) Ca
2+
channels.18 The pancreatic acinar cell expresses all three subtypes
of the IP3R in the apical region, close to the luminal mem-
brane,19–21 but IP3R types 2 and 3 are predominantly responsible
for physiological Ca2+ signalling and enzyme secretion.20 Stimuli
such as CCK,22 the bile acid taurolithocholic acid 3-sulfate
(TLCS),23 24 alcohol25 and fatty acid ethyl ester (FAEE)6 18 cause
intracellular Ca2+ release in pancreatic acinar cells primarily via
IP3Rs, an effect inhibited by double knockout of IP3R types 2
and 318 or by caffeine.8 18
Caffeine (1,3,7-trimethyxanthine) belongs to the methyl-
xanthine class of small, purine-based planar molecules and has
several pharmacological actions,26 including pronounced actions
on Ca2+ signalling.27 Caffeine inhibits Ca2+ release from IP3Rs
by inhibition of phospholipase C-mediated production of IP3
28
or by antagonising IP3Rs
29 through direct binding and reduction
of the open-state probability of IP3Rs.
30 31 Contrarily, caffeine
activates Ca2+ release from ryanodine receptors (RyRs) by
increasing the sensitivity of RyRs to Ca2+ itself as observed in
multiple cells,32 although in pancreatic acinar cells effects on
IP3Rs predominate.
28 29
The effects of caffeine on IP3-mediated Ca
2+ signalling may be
protective in AP since the incidence of AP is inversely propor-
tional to the amount of coffee consumed.33 Caffeine also inhibits
cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP) phosphodiesterase (PDE), which
degrades cAMP and cGMP to non-cyclic forms;34 inhibition of
PDE reduces tumour necrosis factor and leukotriene synthesis,
inhibiting innate immunity.35 Caffeine is a non-selective inhibitor
of adenosine receptors, removing an endogenous brake on neural
activity.26 This stimulant effect of caffeine is the most familiar,
but taken to excess may result in caffeine intoxication with major
central nervous system hyperstimulation.26 Degradation of caf-
feine in the liver forms the dimethylxanthines theophylline
(1,3-dimethylxanthine), paraxanthine (1,7-dimethylxanthine)
and theobromine (3,7-dimethylxanthine), used variously as drugs
with similar actions to those of caffeine, although their actions
on IP3R-mediated signalling have not been clariﬁed. As data
suggest caffeine and/or related methylxanthines may be protect-
ive in AP, we sought to determine their actions on toxin-induced,
IP3R-mediated [Ca
2+]C changes and cell death in vitro, and in
three models of AP in vivo.
MATERIALS AND METHODS
Animals
Adult male CD1 mice (8–12 weeks old) were housed at 23±2°C
under a 12 h light/dark cycle with ad libitum access to standard
laboratory chow and water. For in vivo experiments, animals
were deprived of food but were allowed access to water from
12 h before the start of the experiments.
Measurements of Ca2+ responses, mitochondrial membrane
potential (ΔΨM) and IP3 uncaging
Fresh pancreatic acinar cells were isolated as described.7 Fluo
4-AM (3 μM), ci-IP3/PM (2 mM) and/or tetramethyl rhodamine
methyl ester (TMRM, 37.5 nM) were loaded for 30 min at
room temperature. Confocal images were acquired on a Zeiss
LSM510 system (Carl Zeiss Jena GmbH, Germany) with a 63×
C-Apochromat water immersion objective (NA 1.2). ΔΨM was
recorded in the perigranular mitochondrial cell region. IP3 was
uncaged by UV excitation of whole cells (364 nm, 1% power)
every three seconds where indicated. All ﬂuorescence measure-
ments were expressed as changes from basal ﬂuorescence (F/F0
ratio), where F0 represents initial ﬂuorescence at the start of
each experiment.
In vitro necrosis assays
For CCK-induced cell death, a time-course propidium iodide
(50 mM) necrosis assay was run at 37°C using a POLARstar
Omega Plate Reader (BMG Labtech, Germany). Isolated murine
pancreatic acinar cells (75 mL) were added to a caffeine solution
(75 mL) at selected concentrations or the same volume of
physiological saline (for controls) prior to CCK (50 nM)
addition.
In TLCS-induced cell injury, an end-point propidium iodide
(100 mg/mL) necrosis assay was employed. Cells were incubated
with respective test solutions and agitated by rotary inversion
for 30 min at 37°C, centrifuged (at 260 g for 2 min), resus-
pended and transferred to a microplate. Data were calculated as
background-subtracted (cell-free blanks) percentage of total
death (in 0.02% TritonX). Data were normalised to minimum
and maximum ﬂuorescence using the formula (F-Fmax)/(Fmax −
Fmin)+1. All experiments were in triplicate.
Determination of serum dimethylxanthine and
trimethylxanthine levels by liquid chromatography-mass
spectrometry
Serum was analysed on a QTRAP5500 hybrid triple-
quadrupole/linear ion trap instrument with TurboIon V Ion
source (Applied Biosystems, UK), with inline LC (Ultimate 3000
(Thermoscientiﬁc/Dionex, UK)) and Gemini C18, 3 mm,
2.1×100 mm column (Phenomenex, UK). Eluent A comprised
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H2O/0.1%, formic acid (FA)/1% and tetrahydrofuran v/v, Eluent
B 100% acetonitrile/0.1% FA v/v. The QTRAP5500 was oper-
ated in positive electrospray ionisation (ESI) mode and two
MRM transitions were monitored for caffeine (195.3/138.0 and
195.3/110.0), theobromine (181.1/124.0 and 181.1/96.0), para-
xanthine (181.2/124.0 and 181.2/142.0), theophylline (181.7/
96.0 and 181.7/124.0) and internal standard (paracetamol—
152.064/110.0 and 152.064/65.0) with a 100 ms dwell time.
Also, 1 mL of 100 mM internal standard was added to 50 mL of
each mouse serum sample and subjected to acetone precipitation
(8:1 v/v) at −20°C for 1 h. Samples were centrifuged at 14 000g
for 10 min at 4°C, then supernatant vacuum centrifuged to a
volume of 50 mL. A 10 mL aliquot was injected into the liquid
chromatography-mass spectrometry system. All xanthine serum
concentrations were determined using a calibration curve of 1–
100 mM for each analyte, spiked in mouse serum.
Experimental AP
Hyperstimulation AP was induced by either 7 or 12 intraperito-
neal injections of 50 mg/kg caerulein hourly (CER-AP), with
saline controls. Bile acid AP was induced by retrograde infusion
of 50 mL taurolithocholate acid sulfate (3 mM, TLCS-AP) into
the pancreatic duct as described, with saline injection (sham)
controls.10 36 FAEE-AP was induced by simultaneous intraperi-
toneal injection of ethanol (1.35 g/kg) and palmitoleic acid
(POA, 150 mg/kg), twice at 1 h apart.7 Control mice received
only ethanol (1.35 g/kg) injections. In all models, analgesia with
0.1 mg/kg buprenorphine hydrochloride (Temgesic, Reckitt and
Coleman, Hull, England) was administered. Mice were
humanely killed at designated time points for determination of
severity (see online supplementary materials and methods).
Caffeine administration in vivo
Details of caffeine dose optimisation and administration of
other methylxanthines are described in supplementary materials
and methods. In CER-AP, mice received seven intraperitoneal
injections of 1, 5, 10 or 25 mg/kg of caffeine (called regimen
subsequently) hourly, beginning 2 h after the ﬁrst caerulein
injection, and were humanely killed at 12 h for determination
of severity. The effect of caffeine was also assessed in both 7-
injection and 12-injection CER-AP models at 24 h. In TLCS-AP,
caffeine (25 mg/kg regimen) was begun 1 h after TLCS infusion
and severity determined after humane killing at 24 h. In
FAEE-AP, two intraperitoneal injections of caffeine (25 mg/kg,
1 h apart) were administered from an hour after the second
POA/ethanol injection.
Statistical analysis
Results are presented as means±SEM from three or more inde-
pendent experiments. In all ﬁgures, vertical bars denote mean
±SE values. Statistical analysis was performed using Student’s t
test or analysis of variance in Origin 8.5 (OriginLab,
Northampton, Massachusetts, USA) and a value of p<0.05 con-
sidered signiﬁcant.
Chemicals
Fluo 4-AM, TMRM and Hoechst 33342 were from Thermo
Fisher Scientiﬁc (Waltham, Massachusetts, USA); ci-IP3/PM
from SiChem GmbH (Bremen, Germany). Unless otherwise
stated, all other chemicals were from Sigma (Gillingham, UK) of
the highest grade available.
RESULTS
Inhibition of ACh-induced [Ca2+]C oscillations by caffeine
and its dimethylxanthine metabolites
ACh (50 nM) caused [Ca2+]C oscillations in pancreatic acinar
cells that were concentration-dependently inhibited by caffeine
at 500 mM to 2 mM (ﬁgure 1Ai, ii); 200 mM caffeine resulted
in no signiﬁcant reduction (data not shown). ACh-induced [Ca2
+]C oscillations were also inhibited by 500 mM theophylline
(ﬁgure 1Aiii) and 500 mM paraxanthine (ﬁgure 1Aiv); all
dimethylxanthines inhibited ACh-induced [Ca2+]C signals in a
concentration-dependent manner (ﬁgure 1Av). Theophylline,
paraxanthine and theobromine induced signiﬁcantly more inhib-
ition than caffeine at 500 mM, with paraxanthine showing the
highest potency. In contrast, 1-methylxanthine and xanthine
showed minimal inhibition (see online supplementary
ﬁgure S1A, B).
Inhibition of IP3-mediated [Ca
2+]C signals by caffeine and its
dimethylxanthine metabolites
To investigate whether methylxanthines might directly inhibit
IP3R-mediated Ca
2+ elevations, a membrane-permeable caged IP3
analogue, ci-IP3/PM, was loaded into pancreatic acinar cells.
Repetitive uncaging of ci-IP3/PM caused sustained increases of
[Ca2+]C that were inhibited in a concentration-dependent manner
by caffeine (3 and 5 mM) (ﬁgure 1Bi, ii). Theophylline and para-
xanthine showed similar effects (ﬁgure 1Biii). These results suggest
that methylxanthines inhibit IP3R-mediated [Ca
2+]C signals by an
action on the IP3R.
Caffeine-induced inhibition of CCK-induced [Ca2+]C signals,
ΔΨM loss and cell death
The effects of caffeine on CCK-induced toxic, sustained [Ca2+]C
signals were investigated. An elevated Ca2+ plateau followed
hyperstimulation with 10 nM CCK (ﬁgure 2A), which was
reduced by 27% by 1 mM caffeine (ﬁgure 2Ai), and blocked by
10 mM (ﬁgure 2Aii), effects reversible upon washout. Similar
effects were observed when 10 mM caffeine was applied prior to
10 nM CCK stimulation (see online supplementary ﬁgure S2A).
Methylxanthines are PDE inhibitors and simultaneous
increases in cAMP and cGMP may synergistically inhibit [Ca2+]C
oscillations induced by ACh.37 The potential contribution of
PDE inhibition to the effects of caffeine on CCK-induced sus-
tained Ca2+ signals was investigated using non-hydrolysable ana-
logues of cAMP and cGMP. Addition of 8-bromo-cAMP/GMP
(1 mM) did not affect the CCK-induced [Ca2+]C plateau,
whereas 10 mM caffeine caused complete inhibition (ﬁgure 2B),
suggesting a mechanism independent of intracellular cyclic
nucleotide levels, although both xanthine and non-xanthine PDE
inhibitors were found to inhibit ACh-induced [Ca2+]C oscilla-
tions (see online supplementary ﬁgure S3A–D).
To test potential effects of caffeine on SOCE, internal Ca2+
stores were depleted under Ca2+-free conditions using either
10 nM CCK or 2 mM thapsigargin, an inhibitor of the
sarco-endoplasmic reticulum calcium transport ATPase (SERCA)
and SOCE triggered by reapplication of extracellular Ca2+
(5 mM). Following depletion of internal stores with thapsigar-
gin, caffeine was unable to revert the SOCE-induced Ca2+
plateau (ﬁgure 2Ci). When 10 nM CCK was used to deplete
internal stores, the sustained SOCE plateau was signiﬁcantly
inhibited by 10 mM caffeine in a reversible manner (ﬁgure
2Cii). Following application of both CCK and thapsigargin, caf-
feine did not reduce the associated SOCE (ﬁgure 2Ciii). These
data, summarised in ﬁgure 2Civ, are consistent with an
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inhibitory action of caffeine on IP3R-mediated signalling, not
SOCE per se.
Since sustained [Ca2+]C elevations are known to induce mito-
chondrial dysfunction leading to pancreatic acinar cell necro-
sis,6 7 10 the effects of caffeine on ΔΨM were also evaluated.
Caffeine (both 1 and 10 mM) did not signiﬁcantly affect ΔΨM
on its own (ﬁgure 2Di), but it (10 mM) inhibited the loss of
ΔΨM induced by CCK, reversible on removal of the xanthine
(ﬁgure 2Dii). In a time-course necrotic cell death pathway acti-
vation assay, caffeine (2 and 5 mM) reduced 50 nM
CCK-induced cell death in a concentration-dependent and time-
dependent manner (ﬁgure 2E).
Inhibition of TLCS-induced [Ca2+]C signals and cell death by
caffeine and its dimethylxanthine metabolites
To investigate effects of caffeine on bile acid induced [Ca2+]C
signals, 500 mM TLCS was applied to induce sustained [Ca2+]C
elevations in pancreatic acinar cells. Caffeine concentration-
dependently blocked these TLCS-induced [Ca2+]C elevations.
Thus, 3 mM caffeine partially reduced the plateau (ﬁgure 3Ai),
5 mM caffeine further reduced the sustained elevation with
oscillatory [Ca2+]C rises sometimes superimposed (ﬁgure 3Aii),
while 10 mM completely blocked the sustained elevations
(ﬁgure 3Aiii). Pretreatment of cells with 10 mM caffeine con-
verted 500 mM TLCS-induced [Ca2+]C plateaus into oscillations
(see online supplementary ﬁgure S2B).
The effects of methylxanthines on TLCS-induced necrosis
were investigated using an end-point assay. Caffeine, theophyl-
line and paraxanthine concentration-dependently inhibited
TLCS-induced toxicity (ﬁgure 3Bi–iii). Caffeine induced a slight
but signiﬁcant reduction of TLCS-induced necrosis at 5 mM
and approximately halved this at 10 mM (ﬁgure 3Bi). Similar
patterns were observed for theophylline and paraxanthine over
the range of concentrations tested (ﬁgure 3Bii, iii).
Serum dimethylxanthine and trimethylxanthine levels in
CER-AP
The major metabolites of caffeine that appear in the blood
stream of both humans and rodents are theophylline, para-
xanthine, theobromine and monomethylxanthines (ﬁgure 4A).
The serum levels of these were measured following in vivo caf-
feine administration to mice (25 mg/kg regimen) during
Figure 1 Dimethylxanthine and
trimethylxanthines inhibit acetylcholine
(ACh)-induced and inositol
1,4,5-trisphosphate receptor
(IP3)-induced Ca
2+ signals in isolated
pancreatic acinar cells. (A)
Representative traces of ACh (50 nM)
induced Ca2+ oscillations that were
signiﬁcantly inhibited by caffeine (CAF),
theophylline (TP) and paraxanthine
(PX): (i) partial inhibition by CAF at
500 mM, (ii) almost complete inhibition
by CAF at 2 mM, or (iii) TP at 500 mM
or (iv) PX at 500 mM. (v) Summary
histograms of the inhibitory effects of
CAF, TP, PX and theobromine (TB) on
ACh-induced Ca2+ oscillations at both
500 mM and 2 mM. (B) Representative
traces of Ca2+ elevations (grey)
generated by uncaging of the
membrane permeable IP3 analogue,
ci-IP3/PM (2 mM) that were signiﬁcantly
inhibited by CAF (black): (i) partial
inhibition at 3 mM and (ii) complete
inhibition at 5 mM. (iii) Summary
histograms of inhibitory effects of CAF,
TP and PX on IP3-induced Ca
2+
elevations at 3 and 5 mM. *p<0.05 vs
control group; †p<0.05 vs lower
concentration. Traces are averages of
>20 cells from at least three repeat
experiments. Data normalised from
basal ﬂuorescence levels (F/F0) and are
expressed as means±SE in histograms.
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CER-AP. The serum levels of caffeine were up to 700 μM at
10 min after four caffeine injections (ﬁgure 4B). It peaked at
10 min after seven injections of caffeine at >1 mM and grad-
ually reduced to >600 and >400 μM at 2 and 6 h after last caf-
feine injection, respectively (ﬁgure 4B). Caffeine was the most
abundant xanthine detected (∼1200 mM 10 min after seven
injections), followed by theobromine (∼400 mM), theophylline
(∼300 mM) and paraxanthine (∼150 mM) (ﬁgure 4C). The total
level of dimethylxanthine and trimethylxanthine rose to
>2 mM, a concentration capable of exerting marked inhibition
of CCK-induced Ca2+ signals and cell death.
Effects of dimethylxanthine and trimethylxanthine on the
severity of CER-AP
Since caffeine and its dimethylxanthine metabolites were able to
protect against Ca2+-induced toxicity in vitro, an evaluation of
caffeine was carried out in vivo on CER-AP. In the CER-AP with
seven caerulein injections, at 12 h after the ﬁrst caerulein
Figure 2 Caffeine (CAF) inhibits cholecystokinin (CCK)-induced sustained Ca2+ signals, mitochondrial membrane potential (ΔΨM) loss and cell
death. (A) Representative traces showing the CCK-induced (10 nM) Ca2+ plateau that was signiﬁcantly inhibited by CAF: (i) partial inhibition at
1 mM and (ii) almost complete inhibition at 10 mM, with mean plateau height as % above baseline (inset) showing CAF has a dose-dependent
inhibitory effect on the plateau height (*p<0.05 vs control group; †p<0.05 vs lower concentration). (B) Representative trace showing the lack of
inhibitory effect of non-hydrolysable analogues of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP),
8-bromo-cAMP/cGMP (1 mM) on the CCK-induced Ca2+ plateau, subsequently abolished by CAF (10 mM). (C) Representative traces and summary
histogram showing that CAF (10 mM) (i) did not inhibit the store-operated Ca2+ entry plateau (SOCE) induced by thapsigargin (TG, 2 mM) but (ii)
did inhibit SOCE induced by CCK (10 nM); (iii) CAF did not inhibit SOCE in the presence of TG. (iv) Summary histogram of the effect of CAF on the
SOCE plateau in the presence of TG, CCK, or both (*p<0.05 vs control group). (D) Loss of mitochondrial ΔΨM (tetramethyl rhodamine methyl,
TMRM) induced by CCK (10 nM) was reversed by application of CAF (10 mM), after removal of which the ΔΨM dropped once more and addition of
the protonophore (CCCP, 10 mM) collapsed this to a minimal level: (i) CAF itself had no signiﬁcant effect on ΔΨM; (ii) effect on CAF on
CCK-induced ΔΨM loss. (E) CAF signiﬁcantly inhibited necrotic cell death pathway activation (PI uptake) induced by CCK (50 nM) in a
dose-dependent manner at 2 and 5 mM (*p<0.05 vs control group; †p<0.05 vs CCK only). Traces are averages of >19 cells from at least three
repeat experiments. Data normalised from basal ﬂuorescence levels (F/F0) and are expressed as means±SE in histograms.
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injection there were signiﬁcant elevations of serum amylase,
pancreatic oedema (pancreatic wet to dry ratio), trypsin and
myeloperoxidase (MPO) activity (a marker of neutrophil inﬁltra-
tion), with increases of lung MPO activity, alveolar membrane
thickening and serum interleukin (IL)-6 (ﬁgure 5A–F and online
supplementary ﬁgure S4A, B). To evaluate possible further
distant organ injury, we assessed renal pathology in CER-AP, but
no signiﬁcant effects were seen on serum creatinine and renal
histology, which appeared normal (see online supplementary
ﬁgure S4C, D). Typical histopathological features of AP (oedema,
vacuolisation, neutrophil inﬁltration and necrosis) were con-
ﬁrmed and mirrored by histopathology scores (ﬁgure 5G, H).
In agreement with in vitro ﬁndings, there was dose-
dependency for caffeine in ameliorating the severity of CER-AP
(ﬁgure 5A–F). Using 1 mg/kg caffeine regimen, there was no sig-
niﬁcant effect; with 5 mg/kg caffeine, there was signiﬁcant reduc-
tion of pancreatic oedema and MPO activity, although other
parameters remained unchanged. With 10 and 25 mg/kg caffeine
regimens, there was marked suppression of serum amylase, pan-
creatic oedema, trypsin and MPO activity, whereas elevated lung
MPO activity, alveolar membrane thickening and elevated serum
IL-6 levels remained unsuppressed (ﬁgure 5A–F and online
supplementary ﬁgure 4B). Caffeine had no signiﬁcant effect on
serum creatinine and renal histology (see online supplementary
ﬁgure S4C, D). Caffeine at both 10 and 25 mg/kg markedly
reduced the overall histopathology score (ﬁgure 5Hi). The pro-
tective effect at 25 mg/kg was the most marked (ﬁgure 5G), con-
ﬁrmed by the histopathological scores (ﬁgure 5Hii–iv). In other
experimental AP models, the 25 mg/kg regimen was used,
reduced to two injections for FAEE-AP.
To determine whether caffeine reduced pancreatic injury
through direct vascular actions that increased blood ﬂow,38 we
determined pancreatic blood ﬂow using ﬂuorescent micro-
spheres in untreated animals (see online supplementary
materials and methods), in CER-AP and in CER-AP following
25 mg/kg caffeine regimen. While CER-AP markedly reduced
pancreatic blood ﬂow, caffeine did not have a signiﬁcant effect
on this ﬂow, although there was a trend towards a modest
improvement (see online supplementary ﬁgure S4E).
In contrast of the dramatic effects of caffeine on
caerulein-induced pancreatic injury, theophylline and para-
xanthine did not exert signiﬁcant protective effects in CER-AP
with both 10 and 25 mg/kg regimens (see online supplementary
ﬁgure S5A–E). To further explore these unexpected ﬁndings, the
serum levels of theophylline and paraxanthine were measured
from both dose regimens. Serum levels of theophylline and
paraxanthine 10 min after the last xanthine injection were each
<100 mM in the 25 mg/kg regimen and <50 mM in the 10 mg/
kg regimen (see online supplementary ﬁgure S6). These
dimethylxanthine concentrations were previously shown not to
alter IP3R-mediated [Ca
2+]C signals in vitro, consistent with an
effect of caffeine on this signalling pathway.
Since caffeine treatment was markedly protective in CER-AP at
12 h after induction by seven caerulein injections, its effects on
more severe disease at a later time point were compared (ﬁgure 6).
CER-AP induced by 12 hourly caerulein injections converted mild
necrotising AP into a severe necrotising form characterised by
extensive pancreatic oedema, neutrophil inﬁltration and necrosis
at 24 h after induction (ﬁgure 6Ei–iv). Caffeine (25 mg/kg
regimen) markedly reduced all parameters of pancreatic injury in
both models.
Protective effects of caffeine on TLCS-AP and FAEE-AP
TLCS-AP caused dramatic increases of pancreatic and systemic
injury markers compared with the sham group at 24 h
(ﬁgure 7A–E), with marked histopathological changes (ﬁgure 7F).
Since pancreatic trypsin activity peaks very early after induction of
AP in the bile acid-induced model, this parameter was not
included for severity assessment.36 Caffeine signiﬁcantly reduced
serum amylase (ﬁgure 7A), pancreatic oedema (ﬁgure 7B),
Figure 3 Effects of methylxanthines on taurolithocholic acid 3-sulfate (TLCS)-induced Ca2+ signals and cell death. (A) Representative traces
showing that the TLCS-induced (500 mM) Ca2+ plateau was signiﬁcantly inhibited by caffeine (CAF): (i) partial inhibition at 3 mM, (ii) the sustained
Ca2+ plateau was converted to oscillations at 5 mM and (iii) complete inhibition at 10 mM. (B) (i) CAF signiﬁcantly inhibited necrotic cell death
pathway activation (PI uptake) induced by TLCS (500 mM) in a dose-dependent manner at 5 and 10 mM. Similar effects were also seen for (ii)
theophylline (TP) and (iii) paraxanthine (PX). CAF, TP and PX did not affect basal PI uptake compared with normal controls (*p<0.05 vs control
group; †p<0.05 vs TLCS only). Traces are averages of >20 cells from at least three repeat experiments. Data normalised from basal ﬂuorescence
levels (F/F0) for Ca
2+ signals and from maximal ﬂuorescence levels (F/Fmax) for PI uptake, respectively. Data are expressed as means±SE in
histograms.
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pancreatic MPO activity (ﬁgure 7C) and serum IL-6 (ﬁgure 7E),
but did not affect lung MPO activity (ﬁgure 7D). Caffeine signiﬁ-
cantly reduced the overall histopathological score (ﬁgure 7Gi), as
well as the speciﬁc oedema (ﬁgure 7Gii) and inﬂammation scores
(ﬁgure 7Giii), with a trend to curtail the necrosis score (ﬁgure
7Giv).
Since caffeine inhibits FAEE-induced Ca2+ signals in vitro,7
its effects in FAEE-AP were tested. Co-administration of ethanol
and POA caused typical AP features compared with ethanol
alone (ﬁgure 8A–G).7 Two injections of 25 mg/kg caffeine sig-
niﬁcantly reduced serum amylase, pancreatic oedema, trypsin
and MPO activity, although an increase in lung MPO activity
was observed (ﬁgure 8A–E). The overall histopathological score
(ﬁgure 8Gi) was greatly ameliorated, with signiﬁcantly lowered
oedema (ﬁgure 8Gii) and inﬂammation (ﬁgure 8Giii) with a
trend towards a decrease in necrosis (ﬁgure 8Giv).
DISCUSSION
This study deﬁnes the inhibitory effects of methylxanthines on
IP3R-mediated Ca
2+ release from the pancreatic acinar
endoplasmic reticulum store into the cytosol and their potential
application in AP. It has been shown that caffeine inhibits
IP3Rs
29 as well as IP3 production in a concentration-dependent
manner.28 We found that inhibition of IP3R-mediated Ca
2+
release is attributable at least in part to an action on the IP3R,
since xanthines inhibited IP3R-mediated Ca
2+ release elicited
by uncaged IP3. Caffeine, theophylline and paraxanthine pre-
vented physiological Ca2+ signalling and toxic elevations of
[Ca2+]C induced by agents (CCK and TLCS) that cause AP, in
a concentration-dependent manner (500 mM to 10 mM), also
inhibiting falls in ΔΨM and necrotic cell death pathway activa-
tion. An inhibitory action on PDE preventing cAMP/cGMP
degradation could not account for the effects on toxic [Ca2+]C
overload since additional cAMP/cGMP did not prevent these.
Extending these ﬁndings in vivo, caffeine signiﬁcantly reduced
the severity of multiple, diverse models of AP. The combined
concentrations of dimethylxanthine and trimethylxanthine after
the 25 mg/kg caffeine protocol were within the range over
which effects on both IP3R-mediated Ca
2+ release and toxic
elevations of [Ca2+]C were identiﬁed. Despite the half-life of
Figure 4 Methylxanthine (MX)
structure and determination of serum
di-MX and tri-MX levels in caerulein
acute pancreatitis (CER-AP). (A) (i)
Positions 1, 3 and 7 methylation of the
xanthine structure are shown. (ii)
Dependent on methylation state,
caffeine (CAF) and its MX metabolites
are classed as mono-MX, di-MX and
tri-MX that are listed in the table. (B)
In CER-AP, caffeine at 25 mg/kg (seven
injections hourly) was given
simultaneously with each CER (50 mg/
kg) injection. Mice were sacriﬁced at
different time points to measure serum
caffeine (CAF, tri-MX) levels by LC/MS.
(C) Respective serum di-MX levels and
total di-MX and tri-MX levels showing
peak caffeine concentration at 10 min
after last caffeine/CER injection: CAF
had the highest serum concentration,
followed by theobromine (TB),
theophylline (TP) and paraxanthine
(PX). The cumulative concentration of
di-MX and tri-MX was >2 mM. Values
are means±SE from six mice.
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caffeine in mice of ∼60 min,39 the combined peak concentra-
tions of dimethylxanthine and trimethylxanthine with the
25 mg/kg caffeine regimen were >2 mM, and serum caffeine
was >400 μM 6 h after last caffeine injection. Following
similar protocols of 25 mg/kg theophylline or paraxanthine,
concentrations were far below the effective range on IP3Rs but
within the effective range on PDE (approaching 100 mM
10 min after the last dimethylxanthine injection),26 and no pro-
tective effects on in vivo AP were seen. Nor were signiﬁcant
protective effects seen on pancreatic blood ﬂow with the
25 mg/kg caffeine regimen, to be expected if mediated via PDE
inhibition.38 Since pancreatic cellular injury initiates and deter-
mines severity in AP, the protective effect of caffeine on AP is
likely to have been mediated by inhibition of IP3R-mediated
Ca2+ release.
The concentration range over which caffeine inhibited toxic
[Ca2+]C overload induced by CCK hyperstimulation was similar
to that seen here with quasi-physiological ACh-elicited Ca2+
oscillations, as previously in pancreatic acinar cells28 and per-
meabilised vascular smooth muscle cells.40 There could have
been a cAMP/cGMP-dependent component to inhibition of the
ACh-elicited Ca2+ oscillations since both xanthine-based and
non-xanthine-based PDE inhibitors reduced ACh-elicited Ca2+
oscillations. Nevertheless, PDE inhibition is unlikely to have
contributed to the reduction of toxic [Ca2+]C overload as this
was not affected by application of cell-permeable cAMP/cGMP
analogues, but was immediately reversed upon caffeine adminis-
tration. It is also unlikely that any increase in SERCA activity
occurred in response to caffeine and downstream rises in cyclic
nucleotide levels since no decrease in [Ca2+]C was induced by
Figure 5 Dose-dependent protective effects of caffeine on the severity of caerulein acute pancreatitis (CER-AP) at 12 h. Mice received either
intraperitoneal injections of 50 mg/kg CER (seven injections hourly) or equal amount of saline injections. Caffeine (CAF) at 1, 5, 10 or 25 mg/kg
regimen (seven injections hourly) was begun 2 h after the ﬁrst injection of CER. Mice were sacriﬁced at 12 h after disease induction and assessed
for (A) serum amylase, (B) pancreatic oedema, (C) pancreatic trypsin activity, (D) pancreatic myeloperoxidase (MPO) activity (normalised to CER
group), (E) lung MPO activity (normalised to CER group) and (F) serum interleukin (IL-6). (G) Representative images of pancreatic histopathology for
all groups (H&E, ×200). (H) (i) Overall histopathological score and components: (ii) oedema, (iii) inﬂammation and (iv) necrosis. *p<0.05 vs control
group; †p<0.05 vs CER group. Values are means±SE of 6–8 animals per group.
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analogues of cAMP and cGMP, which have been shown to upre-
gulate SERCA via phospholamban.41 Therefore, the actions of
caffeine on toxic [Ca2+]C overload are consistent with a primary
effect on IP3R-mediated Ca
2+ release.
SOCE in pancreatic acinar and ductal cells occurs predomin-
antly via Orai channels and is regulated in part by TRP chan-
nels.42 Previously we found inhibition of Orai to markedly
reduce CER-AP, TLCS-AP and FAEE-AP.15 Inhibition of TRPC3
was found to reduce a mild model of CER-AP,16 while the non-
selective cation channel TRPV143 44 as well as TRPA144 have
been implicated in neurogenic inﬂammation contributing to AP.
We obtained no data to indicate any direct effect of caffeine on
Orai or TRP channels. On the contrary, SOCE is unlikely to
have been inhibited directly by caffeine since caffeine had no
Figure 6 Caffeine (CAF) protects against pancreatic injury in two caerulein acute pancreatitis (CER-AP) models at 24 h. Mice received either
intraperitoneal injections of 50 mg/kg CER (both 7 and 12 injections hourly) or equal amounts of saline injections. Caffeine (CAF) at the 25 mg/kg
regimen (7 injections hourly) was begun 2 h after the ﬁrst injection of CER. Mice were sacriﬁced at 24 h after disease induction and were assessed
for (A) serum amylase, (B) pancreatic oedema, (C) pancreatic trypsin activity and (D) pancreatic myeloperoxidase (MPO) activity (normalised to CER
group). (E) (i) Overall histopathological score and components: (ii) oedema, (iii) inﬂammation and (iv) necrosis. *Indicates p<0.05. Values are means
±SE of 6–8 animals per group.
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effect on thapsigargin-induced [Ca2+]C plateaus, rather SOCE
will have been inhibited secondarily to reduction of store deple-
tion, the principal driver of SOCE in non-excitable cells.14 15 21
Inhibition of second messenger-mediated Ca2+ release via
RyR ameliorates both caerulein45 and bile acid-induced AP.46
Since caffeine enhances Ca2+ release from RyRs in excitatory
cells,32 and RyRs are major contributors to Ca2+ signalling in
pancreatic acinar cells,23 47 the effects of caffeine in the reduc-
tion of toxic Ca2+ overload observed here might appear contra-
dictory. However, in contrast to the situation in muscle cells,
caffeine can only release Ca2+ in pancreatic acinar cells under
quite exceptional circumstances and then only when present at a
low concentration (1 mM); indeed, this effect is abolished by
stepping up the caffeine concentration.29 Furthermore,
ACh-elicited Ca2+ signalling is blocked by inhibiting IP3Rs
pharmacologically29 and knockout of the principal subtypes
(IP3R2 and IP3R3) results in a failure of Ca
2+ signal generation
and secretion.20 Thus, caffeine is used extensively as an inhibi-
tor of Ca2+ release in fundamental investigations of pancreatic
acinar and other electrically non-excitable cells.27
Little, if any, protective effect of caffeine on experimental AP
can be attributed to actions on adenosine receptors, which have
both inhibitory (A1, A3) and excitatory (A2A, A2B) actions
mediated in part through changes in cAMP.48 Caffeine is an
antagonist of all adenosine receptors; the potency of caffeine is
highest on A2A then A1 receptors at concentrations 10–20
times lower than on PDE.26 In the rat pancreas, few acinar cells
express adenosine receptors;49 differential subtype expression
occurs in vascular endothelium, nerve ﬁbres, islet cells and
ductal cells, with total expression A2A>A2B>A3>A1.48 While
antagonism of the least predominant receptor (A1) previously
reduced pancreatic oedema but no other parameter of experi-
mental AP,49 the majority of data indicate that increasing adeno-
sine receptor activation by reuptake inhibition or administration
Figure 7 Protective effects of caffeine (CAF) on taurolithocholic acid 3-sulfate (TLCS)-acute pancreatitis (AP). Mice received either retrograde
infusion of 50 mL of 3 mM TLCS into the pancreatic duct or underwent sham surgery. CAF at 25 mg/kg (seven injections hourly) was begun 1 h after
TLCS infusion. Mice were sacriﬁced at 24 h after disease induction and were assessed for (A) serum amylase level, (B) pancreatic oedema, (C)
pancreatic myeloperoxidase (MPO) activity (normalised to sham group), (D) lung MPO activity (normalised to sham group) and (E) serum interleukin
(IL-6). (F) Representative pancreatic histopathology for all groups (H&E, ×200). (G) (i) Overall histopathological score and components: (ii) oedema,
(iii) inﬂammation and (iv) necrosis. *p<0.05 vs other two groups. Values are means±SE of 6–11 animals per group.
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of A2 or A3 receptor agonists ameliorates experimental AP.50
Furthermore, adenosine receptor activation has broad anti-
inﬂammatory effects, including reduction of neutrophil recruit-
ment and effector functions via A2A and A2B;51 antagonism of
these receptors may account for the lack of effect of caffeine on
lung MPO or lung histopathology in experimental AP. Similarly,
protective effects via adenosine receptors would be expected at
doses of caffeine that had no (1 mg/kg) or minimal (5 mg/kg)
effect.52
High doses of caffeine were required to reduce the severity of
experimental AP, with the most effective 25 mg/kg regimen
extending into toxicity, indicative of a very narrow therapeutic
index. At this dose, the number of hourly injections had to be
reduced from seven to two in FAEE-AP to avoid mortality; in
CER-AP, 50 mg/kg resulted in caffeine intoxication syndrome,
although at 25 mg/kg no visible side effects were observed. In
humans, even 10 mg/kg caffeine would be likely to induce caf-
feine intoxication, with ﬂorid neuro-excitotoxic and other
undesirable side effects.26 The principal caffeine metabolites in
humans, monkeys, rabbits, rats and mice are similar and do not
differ when given by mouth compared with intraperitoneally.39
Paraxanthine, however, is the most abundant dimethylxanthine
metabolite in humans, while in mice this is theobromine.39
There is marked individual variability in caffeine metabolism
Figure 8 Protective effects of caffeine (CAF) on fatty acid ethyl ester acute pancreatitis. Mice received two intraperitoneal injections of ethanol
(EtOH, 1.35 g/kg) in combination with palmitoleic acid (POA, 150 mg/kg) or equal amounts of EtOH injection only, 1 h apart. CAF at 25 mg/kg
(seven injections hourly) was given 1 h after the second injection of EtOH/POA. Mice were sacriﬁced 24 h after disease induction and assessed for
(A) serum amylase level, (B) pancreatic oedema, (C) pancreatic trypsin activity, (D) pancreatic myeloperoxidase (MPO) activity (normalised to EtOH
group) and (E) lung MPO activity (normalised to EtOH group). (F) Representative pancreatic histopathology for all groups (H&E, ×200). (G) (i) Overall
histopathological score and components: (ii) oedema, (iii) inﬂammation and (iv) necrosis. *p<0.05 vs other two groups. Values are means±SE of 10
animals per group.
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and pharmacokinetics;26 since the half-life in humans typically
ranges from 3 to 7 h, repeated high doses or continuous intra-
venous infusions would be hazardous unless rapid therapeutic
monitoring were to be possible.
Our study has demonstrated proof of principle that caffeine
causes marked amelioration of experimental AP, largely through
inhibition of IP3R-mediated signalling. Medicinal chemistry
starting with the template of caffeine and/or other compounds
that inhibit IP3R-mediated signalling could lead to more potent,
selective and safer drug candidates for AP.
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